Design Therapeutics
Jon DiMaina's work experience includes serving as a Senior Research Associate at Design Therapeutics starting in 2023. Prior to that, they worked as a Research Associate at the same company from February 2022 to January 2023. Before joining Design Therapeutics, Jon worked as a Cell Associate I at Cell Applications, Inc. from 2017 to 2018.
Jon DiMaina completed their Bachelor of Science (B.S.) degree in Biology at Coastal Carolina University from 2010 to 2012. Following this, they pursued a Master of Science (MS) in Biomedical Sciences from the Medical University of South Carolina, which they completed from 2014 to 2017.
Design Therapeutics
1 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.